No Data
No Data
Express News | Nurix Therapeutics Shares Are Trading Higher After Truist Securities Initiated Coverage on the Stock With a Buy Rating and Announced a Price Target of $36
Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics
Nurix Therapeutics Initiated at Buy by Truist Securities
Truist Financial Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $36
Express News | Nurix Therapeutics Inc : Truist Securities Initiates With Buy Rating; Price Target $36
Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $30
No Data